pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids

Vaccine

Volumn 24, Issue 21, 2006, Pages 4671-4676

  Williams, James A ^a   Luke, Jeremy ^a   Johnson, Lance ^a,b   Hodgson, Clague ^a  

^a NATURE TECHNOLOGY CORPORATION   (United States)

^b Midland Lutheran College   (United States)

Author keywords

Antigen presentation; DNA vaccine; Plasmid

Indexed keywords

DNA VACCINE;

ARTICLE; CANCER THERAPY; DNA VECTOR; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; GENE TARGETING; IN VITRO STUDY; MOLECULAR CLONING; PLASMID; PRIORITY JOURNAL;

BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; GENETIC VECTORS; PLASMIDS; VACCINES, DNA;

EID: 33646839635     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.033     Document Type: Article

References (32)

1. Lemieux P. Technological advances to increase immunogenicity of DNA vaccines. Expert Rev Vaccines 1 (2002) 85-93
2. Cohen A.D., Boyer J.D., and Weiner D.B. Modulating the immune response to genetic immunization. FASEB J 12 (1998) 1611-1626
3. Zhongming L., Howard A., Kelley C., Delogu G., Collins F., and Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun 67 (1999) 4780-4786
4. Gerber L., Kodukula K., and Udenfriend S. Phosphatidylinositol glycan (PI-G) anchored membrane proteins. J Biol Chem 267 (1992) 12168-12173
5. Wu T., Guarnieri F.G., Staveley-O'Carroll K.F., Viscidi R.P., Levitsky H.I., Hedrick L., et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci 92 (1995) 11671-11675
6. August JT, Pardoll DM, Guarnieri FG. Lysosomal targeting of immunogens. US Patent No. 5,633,234; 1997.
7. Weiss R., Durnberger J., Mostbock S., Scheiblhofer S., Hartl A., Breitenback M., et al. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine 18 (2000) 815-824
8. Rodriguez F., An L.L., Harkins S., Zhang J., Yokoyama M., Widera G., et al. DNA immunization with Minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol 72 (1998) 5174-5181
9. Delogu G., Howard A., Collins F.M., and Morris S.L. DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. Infect Immun 68 (2000) 3097-3102
10. Fanning S.L., Czesny B., Sedegah M., Carucci D.J., van Gemert G.J., Eling W., et al. A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230. Vaccine 21 (2003) 3228-3235
11. Lu Y., Raviprakash K., Leao I.C., Chikhlikar P.R., Ewing D., Anwar A., et al. Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine 21 (2003) 2178-2189
12. Bucht G., Sjolander K.B., Eriksson S., Lindgren L., Lundkvist A., and Elgh F. Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein. Vaccine 19 (2001) 3820-3829
13. Drew D.R., Lightowlers M., and Strugnell R.A. Humoral immune responses to DNA vaccines expressing secreted, membrane bound, and non-secreted forms of the Taenia ovis 45W antigen. Vaccine 18 (2000) 2522-2532
14. Rice J., King C.A., Spellerberg M.B., Fairweather N., and Stevenson F.K. Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines. Vaccine 17 (1999) 3030-3038
15. Leifert J.A., Rodriguez-Carreno M.P., Rodriguez F., and Whitton J.L. Targeting plasmid-encoded proteins to the antigen presentation pathways. Immun Rev 199 (2004) 40-53
16. Hartikka J., Sawdey M., Cornefert-Jensen F., Margalith M., Barnhart K., Nolasco M., et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 7 (1996) 1205-1217
17. Ramanathan M.P., Ayyavoo V., and Weiner D.B. Choice of expression vector alters the localization of a human cellular protein DNA. Cell Biol 20 (2001) 101-105
18. Zinckgraf J.W., and Silbart L.K. Modulating gene expression using DNA vaccines with different 3′-UTRs influence antibody titer, seroconversion and cytokine profiles. Vaccine 21 (2002) 1640-1649
19. Hodgson C, Zink MA, Xu G. Vectors for Gene Self-assembly. US Patent 6,410,220.
20. Cranenburgh R.M., Hanak J.A., Williams S.G., and Sherratt D.J. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res 29 (2001) 26
21. Points to consider on Plasmid DNA Vaccines for Preventive Infectious Diseases Indications. FDA Docket No. 96N-0400.
22. Engels P., and Meyer P. Inactivation of the transcriptional-dependent inhibition of plasmid replication: a selection method for cloning large DNA fragments. Biotechniques 14 (1993) 324-325
23. Levy J. Avoidance of undesirable replication intermediates in plasmid propagation. US Patent Application US2003180949; 2003.
24. Piechocki M.P., Pilon S.A., and Wei W.Z. Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2. J Immunol 167 (2001) 3367-3374
25. Liu W.J., Zhao K.N., Gao F.G., Leggatt G.R., Fernando G.J.P., and Frazer I.H. Polynucleotide viral vaccines: codon optimization and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine 20 (2001) 862-869
26. Carucci D.J. Genomic tools for gene and protein discovery in malaria: toward new vaccines. Vaccine 19 (2001) 2315-2318
27. Capecchi B., Serruto D., Adu-Bobie J., Rappuoli R., and Pizza M. The genome revolution in vaccine research. Curr Issues Mol Biol 6 (2004) 17-27
28. Leite J.P., Cousin C., Heysen A., and D'Halluin J.C. Negative effect of a cis-acting pBR322 element on adenovirus E1a gene expression. Gene 82 (1989) 351-356
29. Peterson D.O., Beifuss K.K., and Morley K.L. Context-dependent gene expression: cis-acting negative effects of specific prokaryotic plasmid sequences on eukaryotic genes. Mol Cell Biol 7 (1987) 1563-1567
30. Tully D.B., and Cidlowski J.A. pBR322 contains glucocorticoid regulatory element DNA consensus sequences. Biochem Biophys Res Commun 144 (1987) 1-10
31. Ghersa P., Whelan J., Pescini R., DeLamarter J.F., and Hooft van Huijsduijnen R. Commonly used cat reporter vectors contain a cAMP-inducible, cryptic enhancer that co-operates with NF-kappa B-sites. Gene 151 (1994) 331-332
32. Kushner P.J., Baxter J.D., Duncan K.G., Lopez G.N., Schaufele F., Uht R.M., et al. Eukaryotic regulatory elements lurking in plasmid DNA: the activator protein-1 site in pUC. Mol Endocrinol 8 (1994) 405-407